GVHD Prophylaxis with Short Course MTX and Tacrolimus in HLA-Haploidentical Hematopoietic Stem Cell Transplantation Using Post-Transplant High Dose Cyclophosphamide

被引：1
|
作者：
Ohata, Kinya [1 ]
Aoki, Go [1 ]
Takamatsu, Hiroyuki [1 ]
Ishiyama, Ken [1 ]
Kondo, Yukio [1 ]
Yamazaki, Hirohito [1 ]
Nakao, Shinji [1 ]
机构：
[1] Kanazawa Univ Hosp, Dept Hematol, Kanazawa, Ishikawa, Japan
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2016年 / 22卷 / 03期
关键词：
D O I：
10.1016/j.bbmt.2015.11.885
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
562
引用
收藏
页码：S374 / S374
页数：1
相关论文
共 50 条
  • [41] The Impact of Peripheral Stem Cell As a Stem Cell Source on Gvhd for Patients Receiving Post-Transplant High Dose Cyclophosphamide As Gvhd Prophylaxis after an Allogeneic Transplant
    Shestovska, Yuliya
    Joshi, Shalina
    Fung, Henry C.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S186 - S187
  • [42] Post-transplantation cyclophosphamide to facilitate HLA-haploidentical hematopoietic cell transplantation: Mechanisms and results
    Elmariah, Hany
    Fuchs, Ephraim J.
    [J]. SEMINARS IN HEMATOLOGY, 2019, 56 (03) : 183 - 189
  • [43] Effect of peptide-binding motif on survival of HLA-haploidentical transplantation with post-transplant cyclophosphamide
    Ido, Kentaro
    Nakamae, Hirohisa
    Hattori, Norimichi
    Kanaya, Minoru
    Morita, Kaoru
    Hino, Masayuki
    Ohigashi, Hiroyuki
    Fukuda, Takahiro
    Eto, Tetsuya
    Nagafuji, Koji
    Hiramoto, Nobuhiro
    Maruyama, Yumiko
    Ota, Shuichi
    Matsuoka, Ken-ichi
    Ando, Toshihiko
    Akasaka, Takashi
    Mori, Yasuo
    Kamimura, Tomohiko
    Kawakita, Toshiro
    Kawamura, Koji
    Kanda, Junya
    Onizuka, Makoto
    Atsuta, Yoshiko
    Murata, Makoto
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2024,
  • [44] HLA-Haploidentical Vs Mismatched Unrelated Donor Transplants with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis for AML and MDS: Is There a Winner?
    Modi, Dipenkumar
    Shatta, Maya
    Kim, Seongho
    Deol, Abhinav
    Kin, Andrew
    Alavi, Asif
    Ayash, Lois
    Ratanatharathorn, Voravit
    Uberti, Joseph P.
    [J]. BLOOD, 2022, 140
  • [45] Haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for patients with high-risk hematologic malignancies
    Carella, A. M.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 : S183 - S184
  • [46] HLA-haploidentical allografting with high-dose post-transplant cyclophosphamide: clinical outcomes and immune-reconstitution
    Busca, A.
    Mafnni, E.
    Ferrando, F.
    Dellacasa, C.
    Polito, R.
    Saraci, E.
    Giaccone, L.
    Boccadoro, M.
    Omede, P.
    Bruno, B.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 : S117 - S117
  • [47] Early administration of cyclosporine may reduce the incidence of cytokine release syndrome after HLA-haploidentical hematopoietic stem-cell transplantation with post-transplant cyclophosphamide
    Naoki Kurita
    Tatsuhiro Sakamoto
    Takayasu Kato
    Manabu Kusakabe
    Yasuhisa Yokoyama
    Hidekazu Nishikii
    Mamiko Sakata-Yanagimoto
    Naoshi Obara
    Yuichi Hasegawa
    Shigeru Chiba
    [J]. Annals of Hematology, 2021, 100 : 1295 - 1301
  • [48] Early administration of cyclosporine may reduce the incidence of cytokine release syndrome after HLA-haploidentical hematopoietic stem-cell transplantation with post-transplant cyclophosphamide
    Kurita, Naoki
    Sakamoto, Tatsuhiro
    Kato, Takayasu
    Kusakabe, Manabu
    Yokoyama, Yasuhisa
    Nishikii, Hidekazu
    Sakata-Yanagimoto, Mamiko
    Obara, Naoshi
    Hasegawa, Yuichi
    Chiba, Shigeru
    [J]. ANNALS OF HEMATOLOGY, 2021, 100 (05) : 1295 - 1301
  • [49] Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease
    Wiebking, Volker
    Hutker, Sebastian
    Schmid, Irene
    Immler, Stefanie
    Feuchtinger, Tobias
    Albert, Michael H.
    [J]. ANNALS OF HEMATOLOGY, 2017, 96 (08) : 1373 - 1377
  • [50] Impact of HLA disparity on GvHD and relapse rate in haploidentical transplants followed by high dose post-transplant cyclophosphamide
    Raiola, A. M.
    Sacchi, N.
    Garbarino, L.
    Bregante, S.
    DiGrazia, C.
    Dominietto, A.
    Giannoni, L.
    Gualandi, F.
    Lamparelli, T.
    Marani, C.
    Vanlint, M. T.
    Varaldo, R.
    Ibatici, A.
    Bacigalupo, A.
    Angelucci, E.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 : S44 - S45
12345